drugset / Trial / NCT00825227

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

NCT00825227

Phase 2 Terminated 10 enrolled Cephalon
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluate the Safety and Efficacy of Armodafinil Treatment for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents

Timeline

Start
2008-12
Primary completion
2009-10
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Armodafinil Small molecule 150 mg